Sort
39,280 grants matching “leukemia”
DC-ASGPR as Novel Target for Controlling GVHD and Allograft Rejection
$392,000Sangkon Oh · Baylor Research Institute · R01 · FY2015 · AI
DC-ASGPR as Novel Target for Controlling GVHD and Allograft Rejection
$392,000Sangkon Oh · Baylor Research Institute · R01 · FY2017 · AI
Support for Infrastructure of Childhood Leukemia Environmental Research
$391,983Catherine Metayer · University Of California Berkeley · R24 · FY2017 · ES
Transcription Factor Mutants of Yeast
$391,975Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · GM
STUDIES OF BCR/ABL LEUKEMOGENESIS IN MICE
$391,956Immune Disease Institute, Inc. · R01 · FY2002 · CA
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
$391,951Scott A Armstrong · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Human Genes Affecting Chromosome Metabolism and Stress Response
$391,895Daniel Menendez Rendon · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Mechanism and Regulation of Human Nonhomologous DNA End Joining
$391,875Michael R Lieber · University Of Southern California · R01 · FY2018 · CA
Mechanism and Regulation of Human Nonhomologous DNA End Joining
$391,875Michael R Lieber · University Of Southern California · R01 · FY2017 · CA
Mechanism and Regulation of Human Nonhomologous DNA End Joining
$391,875Michael R Lieber · University Of Southern California · R01 · FY2021 · CA
Mechanism and Regulation of Human Nonhomologous DNA End Joining
$391,875Michael R Lieber · University Of Southern California · R01 · FY2020 · CA
Novel mechanisms of immune activation following allogeneic, hematopoietic stem ce
$391,855John James Letterio · Case Western Reserve University · R01 · FY2013 · HL
Function of PHD Domain Proteins in Chromatin Regulation
$391,832Or P. Gozani · Stanford University · R01 · FY2019 · GM
A Negative Paracrine Loop in Megakaryopoiesis
$391,816Mortimer Poncz · University Of Pennsylvania · P01 · FY2008 · HL
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$391,800Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2021 · GM
ANTITUMOR PROPERTIES OF DISCODERMOLIDE AND DERIVATIVES
$391,761Harbor Branch Oceanographic Inst, Inc. · R01 · FY2000 · CA
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
$391,755Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2009 · DK
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
$391,755Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2008 · DK
Olig2 Antagonists for Targeted Therapy of Pediatric Astrocytomas
$391,728Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Characterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesis
$391,699Effie Apostolou · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$391,697Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
$391,652Matthew H Porteus · Stanford University · R01 · FY2015 · AI
Cohesin Mutations in Acute Myelogenous Leukemia
$391,588Sridhar Rao · Versiti Wisconsin, Inc. · R01 · FY2017 · CA
PEDIATRIC ONCOLOGY GROUP
$391,587Baylor College Of Medicine · U10 · FY2000 · CA
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$391,554Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2022 · GM